Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia
Copper-62 labeled diacetyl-bis (N 4-methylthiosemicarbazone) (62Cu-ATSM) has been proposed as a generator produced positron-emitting tracer for hypoxic tissue imaging. To clarify the usefulness of62Cu-ATSM for myocardial ischemia,62Cu-ATSM PET was performed in 7 patients with coronary artery disease. Increased myocardial uptake of62Cu-ATSM was observed (myocardium/blood ratio: 3.09) in one patient with unstable angina, who had increased18F-fluorodeoxyglucose (18F-FDG) uptake under the fasting condition. The other 6 patients, who were clinically stable, did not have increased62Cu-ATSM uptake, although abnormal18F-FDG uptake was seen in 4 patients. This preliminary study suggests that62Cu-ATSM is a promising PET tracer for hypoxic imaging in acute ischemia.
Key wordscopper-62 ATSM hypoxia coronary artery disease fluorine-18 FDG PET
Unable to display preview. Download preview PDF.
- 6.Linder KE, Chan YW, Cyr JE, Malley MF, Nowotnik DP, Nunn AD. Technetium-O(PnAO-(2-nitroimidazole)) [BMS181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis characterization and xanthine oxidase-catalyzed reduction.J Med Chem 1994; 37: 9–17.CrossRefPubMedGoogle Scholar
- 9.Fujibayashi Y, Taniuchi H, Wada A, Yonekura Y, Konishi J, Yokoyama A. Differential mechanism of retention of Cu-pyruvaldehyde-bis(N 4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging.Ann Nucl Med 1995; 9: 1–5.PubMedCrossRefGoogle Scholar
- 11.Matsumoto K, Fujibayashi Y, Yonekura Y. Application of the new zinc-62/copper-62 generator: an effective labeling method for62Cu-PTSM.Nucl Med Biol 1992; 19: 39–44.Google Scholar